Concentration-response assay for inverse agonists of the thyroid stimulating hormone receptor: ELISA activity detection
TSH is an alpha/beta heterodimeric glycoprotein hormone secreted from the anterior pituitary gland which belongs to the glycoprotein hormone family. The actions of TSH are mediated by a seven-transmembrane receptor, which upon TSH binding couples preferentially to the G-alpha (s) protein (Gs), resulting in activation of adenylate cyclase and increase in cyclic adenosine 3', 5' monophosphate more ..
BioActive Compounds: 5
Depositor Specified Assays
TSH is an alpha/beta heterodimeric glycoprotein hormone secreted from the anterior pituitary gland which belongs to the glycoprotein hormone family. The actions of TSH are mediated by a seven-transmembrane receptor, which upon TSH binding couples preferentially to the G-alpha (s) protein (Gs), resulting in activation of adenylate cyclase and increase in cyclic adenosine 3', 5' monophosphate (cAMP). The TSH receptor (THSR) is mainly expressed in thyroid follicular cells and regulates their growth and function. This cell based assay was conducted on a TSHR transfected HEK 293 cell line, measuring cAMP stimulation using antibody-based Homogeneous Time Resolved Fluorescence (HTRF).
Our goal is to identify small molecules that will inhibit (antagonize) the thyroid-stimulating hormone receptor (TSHR), a member of the 7 transmembrane-spanning receptor (7TMR) family of cell surface receptors. TSHR-mediated hyperthyroidism is important in thyroid pathology. The development of small molecule antagonists of TSHR may lead to therapeutic approaches for TSHR-mediated hyperthyroidism caused by constitutively activating mutations or stimulating auto-antibodies associated with Graves' disease. Graves' disease is the leading cause of hyperthyroidism and is caused by autoantibodies that stimulate TSHR (TsAbs) causing thyroid growth and unregulated overproduction of thyroid hormones and existing treatments have liabilities (agranulocytosis). In addition, TSHRs are known to be expressed in multiple extrathyroidal tissues including bone, brain, kidney, testis, fat and cells of the immune system but the role of the TSHR in these tissues is not clear. Therefore, TSHR antagonists/inverse agonists could be used as probes of extrathyroidal TSHR function. Finally, TSHR inverse agonists, which are a subclass of antagonists that inhibit agonist-independent (or basal or constitutive) TSHR signaling, could be used to inhibit TSH-independent signaling in patients with recurrent or metastatic thyroid cancer who are receiving thyroid hormone to suppress TSH.
A confirmatory assay of TSHR inverse agonists was conducted on a HEK 293 cell line stably expressing the TSHR, using an ELISA based cAMP competition assay using cAMP-Screen Direct System (Applied Biosystems, Foster City, CA) to measure cAMP stimulation.
Transiently transfected HEK-EM 293 cells or cells stably expressing TSHRs were seeded into 96-well plates at a density of 7 x104 cells per well in DMEM containing 10% FBS. Cells were cultured for 24 h before incubation for 20 min in HBSS/10 mM HEPES (pH 7.4). To determine basal cAMP production, cells were incubated for 1 h at 37 C in a humidified incubator in HBSS/HEPES containing 1mM IBMX (Sigma Chemical Co., St. Louis, MO) in the presence or absence of compound. The levels of cAMP in cells incubated in HBSS/HEPES without IBMX were subtracted in all experiments. After aspiration of the incubation medium, cells were lysed using lysis buffer of the cAMP-Screen Direct system (Applied Biosystems, Foster City, CA). The cAMP content of the cell lysate was determined using the method described in the manufacturer's protocol. The chemiluminescence signal was measured in a VICTOR3 V 1420 multilabel counter (PerkinElmer, Norwalk, CT). The potency (IC50) of the ligands were obtained from dose-response curves by data analysis with GraphPad Prism 4 for Windows.
Active compounds were given a score of 100, inactive compounds were given a score of 0.
* Activity Concentration.
Data Table (Concise)